• Antibody-drug conjugates
• Targeting platform – 'OptiLink'
• Light activated cancer therapy – 'ProstaLite'
• MRI contrast agents & imaging
• Photosensitiser innovations
• Additional products and applications

• Investment History & Strategy
• Partnering opportunities

• Press Releases
• News Items
• Scientific Publications

• Background
• Achievements
• The Team
• Sitemap

Partner Opportunities

Are you seeking an effective means for targeting your drugs?

Do you have:-

• antibodies for which you want to extend their application / patent life?
• photosensitiser / drugs that you want to deliver more efficiently?

Do you want:-

• more effective photosensitisers?
• a product for treating prostate and other cancers?
• novel MRI contrast agents for imaging?
• a 'See and Treat' product?
• a technology platform with multiple product opportunities?

If the answer to any of these questions is yes, then please contact us to initiate a collaboration and licensing dialogue on ProstaLite, the OptiLink technology platform and/or PhotoBiotics’ novel photosensitisers.